Is there a correlation between sleep apnea and vertigo or benign positional vertigo (BPV)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sleep Apnea and Vertigo: Evidence of Correlation

Yes, there is a significant correlation between sleep apnea and both vertigo and benign paroxysmal positional vertigo (BPPV), with sleep apnea patients experiencing substantially higher rates of dizziness and vestibular disorders compared to the general population.

Epidemiological Evidence

The relationship between sleep apnea and dizziness is well-documented across multiple study designs:

  • Higher incidence of dizziness in sleep apnea patients: People with sleep apnea demonstrate significantly elevated rates of dizziness compared to healthy controls, with this association consistently identified across case reports, cross-sectional studies, and retrospective cohort analyses 1.

  • Increased prevalence of sleep apnea among dizzy patients: Conversely, patients presenting with dizziness show a greater prevalence of sleep apnea than the general population 1.

  • Dose-response relationship: The severity of dizziness correlates significantly with the degree of sleep apnea and its related parameters across the majority of studies 1.

Specific Vestibular Disorders Associated with Sleep Apnea

Sleep apnea patients exhibit dramatically elevated risks for specific vestibular conditions:

  • BPPV correlation: Sleep disorders occur in 54.39% of BPPV patients compared to only 14.28% of healthy controls, representing a statistically significant difference (p = 0.00004) 2.

  • Vestibular migraine: Occurs at much higher frequency in sleep apnea patients than in the general population 3.

  • Menière's disease: Substantially elevated incidence among sleep apnea patients, likely due to enhanced vascular risks associated with sleep apnea 3.

  • Sudden sensorineural hearing loss: Occurs at greatly elevated rates in sleep apnea patients 3.

Clinical Presentation of Sleep Apnea-Related Dizziness

The dizziness associated with sleep apnea has distinctive characteristics:

  • Brief recurrent vertigo spells: Repeated episodes of sudden momentary vertigo are common, with brief spells of nonpositional vertigo recurring throughout the day 3.

  • Phenotypic similarity to vestibular paroxysmia: These brief, recurrent nonpositional vertigo episodes respond to treatment of sleep apnea and may represent a distinct vestibular entity 3.

  • Snoring as a clinical clue: A history of snoring should be actively sought in all dizzy patients as a screening tool 3.

Treatment Response Evidence

The therapeutic relationship provides strong support for causality:

  • CPAP effectiveness: Continuous positive airway pressure treatment consistently leads to either complete or partial resolution of dizziness in people with sleep apnea across multiple studies 1.

  • Long-term resolution: Among patients with complete resolution of dizziness following sleep apnea treatment, mean follow-up of 4 years demonstrates sustained benefit 3.

  • Uvulopalatopharyngoplasty: Surgical treatment of sleep apnea also results in dizziness resolution, supporting the causal relationship 3.

Comparative Sleep Quality in Vestibular Disorders

When comparing different vestibular conditions:

  • VM versus BPPV: Vestibular migraine patients have significantly higher incidence of sleep disorders (79.16%) compared to BPPV patients (54.39%), with p = 0.008 2.

  • Severe obstructive sleep apnea: VM patients demonstrate significantly higher rates of severe obstructive sleep apnea hypoventension syndrome (p = 0.001) and periodic leg movement in sleep (p = 0.016) compared to BPPV patients 2.

  • Sleep architecture differences: VM patients show significantly lower sleep efficiency (p < 0.001) and N3 sleep (p < 0.001), with higher wake time after sleep onset (p < 0.001) compared to BPPV patients 2.

Clinical Implications and Screening Recommendations

Clinicians should actively screen for sleep apnea in all patients presenting with dizziness or vertigo, particularly those with recurrent brief vertigo spells, vestibular migraine, Menière's disease, or sudden hearing loss.

  • The mean age of affected patients is 55 years with mean BMI of 31, providing a typical demographic profile 3.

  • Sleep apnea evaluation should include both subjective assessment (Pittsburgh Sleep Quality Index) and objective monitoring (polysomnography) when clinically indicated 2.

Pathophysiological Mechanism

The likely mechanism linking sleep apnea to vestibular disorders involves:

  • Vascular risk enhancement: The greatly elevated risk of migraine, Menière's disease, and sudden sensorineural hearing loss are likely due to enhanced vascular risks associated with sleep apnea 3.

  • Intermittent hypoxia effects: Sleep apnea-induced intermittent hypoxia may directly affect vestibular structures through vascular compromise 3.

Common Pitfalls to Avoid

  • Overlooking sleep history: Failing to inquire about snoring and sleep quality in dizzy patients misses a treatable underlying cause 3.

  • Treating vertigo without addressing sleep apnea: In patients with both conditions, treating only the vestibular symptoms without addressing sleep apnea may result in incomplete symptom resolution 2.

  • Assuming all dizziness is peripheral: The brief recurrent vertigo pattern associated with sleep apnea may be misdiagnosed as other vestibular conditions 3.

References

Research

Relationship between sleep apnea and dizziness: a scoping review.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2025

Research

The Clinical Spectrum of Dizziness in Sleep Apnea.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.